abstract |
The invention provides methods and compositions for the treatment, prevention and / or improvement of psoriasis based on compounds having a calcitonin-related gene peptide (OGRP) antagonistic effect. Methods are also described for identifying compounds with eGRP antagonist activity which are thereby suitable candidate compounds for the treatment of psoriasis. |